Frontlight ResearchEarly access
Trial site
Texas Oncology-Longview Cancer Center
- 2running trials
- 6closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Triple-negative breast cancer3 trials
- Lung cancer2 trials
- Pancreatic cancer2 trials
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Status
- Completed4 trials
- Terminated2 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Pfizer2 trials
- Astellas Pharma Global Development, Inc.1 trial
- G1 Therapeutics, Inc.1 trial
- National Cancer Institute (NCI)1 trial
- NRG Oncology1 trial
- and 2 more
Running trials
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Terminated
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026